Charles Wagner

Executive Vice President and Chief Operating & Financial Officer · Vertex Pharmaceuticals

Biopharmaceuticals

Charles Wagner is chief operating and financial officer of Vertex Pharmaceuticals. He has held CFO positions across life-sciences tools, diagnostics and software businesses, following an early career in accounting and consulting.

Last reviewed: Nov 2, 2026

Charles Wagner

Executive Vice President and Chief Operating & Financial Officer
Vertex Pharmaceuticals

Last Reviewed: November 2, 2026

Executive Summary

Charles Wagner is chief operating and financial officer of Vertex Pharmaceuticals. He has held CFO positions across life-sciences tools, diagnostics and software businesses, following an early career in accounting and consulting.

Career Highlights

  • Joined Vertex as CFO in April 2019 and added chief operating officer responsibilities in July 2025.
  • Previously served as CFO of Ortho Clinical Diagnostics, Bruker, Progress Software and Millipore.
  • Serves on The TJX Companies’ board and its Audit and Finance Committee.

Professional Journey

Wagner began his career at Coopers & Lybrand and worked in accounting analysis at Millipore before joining Bain & Company in 1997. His consulting experience preceded a return to Millipore in 2002.

At Millipore, he became vice president of strategy and corporate development in 2003. His responsibilities included strategy, acquisitions, alliances, investor relations and corporate communications. He became CFO in 2007, overseeing finance, accounting and information technology until the company’s acquisition by Merck KGaA in 2010.

Wagner joined Progress Software in November 2010 as executive vice president of finance and administration and CFO. He moved to Bruker as executive vice president and CFO in July 2012, having previously served on its board and audit committee. In June 2015, he joined Ortho Clinical Diagnostics, where his finance responsibilities encompassed treasury, tax, lender relations and transactions.

Vertex appointed Wagner CFO in April 2019. He added chief operating officer responsibilities in July 2025. His current portfolio includes finance and accounting, human resources, internal audit, investor relations, technology and data functions, business-development transactions and alliance management, corporate communications and facilities.

His outside governance work includes The TJX Companies, whose board he joined in September 2023, and earlier board service at Good Start Genetics. He was named to the Empower Top 50 Advocates lists in 2023 and 2024.

Education

Wagner holds a Bachelor of Science in accounting from Boston College and an MBA from Harvard Business School.